Japan city New Delhi India city Mumbai hospital covid-19 Government patient Japan city New Delhi India city Mumbai

Glenmark starts clinical trial of potential covid-19 drug favipiravir in India

Reading now: 380
www.livemint.com

NEW DELHI: Glenmark Pharmaceuticals Ltd has initiated phase 3 clinical trials in India on the use of generic antiviral drug favipiravir for treatment of mild to moderate covid-19, a study which the Mumbai-based drug-maker expects to complete by August.

Drug Controller General of India V.G. Somani had in late April approved Glenmark’s plan to conduct phase 3 trials on the use of the drug.

Clinical trials have commenced and over 10 leading government & private hospitals in India are being enrolled for the study, the company said in an exchange filing.

Favipiravir is a generic version of Avigan of Japan’s Fujifilm Toyama Chemical Co Ltd, a subsidiary of Fujifilm Corporation.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA